MondayNov 03, 2008 4:47 am

Bravo Venture Group Inc. (TSX: BVG CN)

Bravo Venture Group Inc. (TSX: BVG CN) is devoted to their shareholders and focused on increasing the value of the company by leveraging their experienced management team that has a successful track record of identifying, exploring and developing gold/silver properties within North America that exhibit potential for discovery. The company’s current focus is on N.W. British Columbia, Nevada, and S.E. Alaska. For further information, visit the Company's web site at www.bravoventuregroup.com.

Continue Reading

MondayNov 03, 2008 4:46 am

Brainstorm Cell Therapeutics, Inc. (OTC BB: BCLI)

Brainstorm Cell Therapeutics, Inc. (OTC BB: BCLI), a leading developer of stem cell technologies, is committed to providing treatments for neurodegenerative diseases that are currently incurable. The company’s focus is on developing NTF cells from the patient's own bone marrow to treat, Parkinson, ALS, and Spinal Cord Injury. The Brainstorm management and scientific teams are devoted to the company’s mission to regenerate the mind in their lifetime. For further information, visit the Company's web site at www.brainstorm-cell.com.

Continue Reading

MondayNov 03, 2008 4:45 am

BPZ Resources, Inc. (AMEX: BPZ)

BPZ Resources, Inc. (AMEX: BPZ), an oil and gas exploration and production company, has exclusive license contracts for oil and gas exploration and production covering about 2.4 million acres in four properties in northwest Peru. The company also owns a minority working interest in a producing property in southwest Ecuador. Currently, BPZ Resources is focusing its efforts on the execution of an integrated gas-to-power strategy, which includes generation and sale of electric power in Peru and sales of gas into Ecuador. For further information, visit the Company's web site at www.bpzenergy.com.

Continue Reading

MondayNov 03, 2008 4:44 am

Boots & Coots International Well Control, Inc. (AMEX: WEL)

Boots & Coots International Well Control, Inc. (AMEX: WEL) is focused on offering its suite of integrated pressure control and related services to onshore and offshore oil and gas exploration and development companies around the world. The company manufactures much of its own equipment, resulting in a faster, fit-for-purpose product. For faster, more economical workovers under live well conditions, Boots & Coots’ truck-mounted hydraulic rig-assist units provide for quick and easy rig-ups. For further information, visit the Company's web site at www.bootsandcoots.com.

Continue Reading

MondayNov 03, 2008 4:44 am

Pacific Ridge Exploration Ltd. (TSX: PEX CN)

Pacific Ridge Exploration Ltd. (TSX: PEX CN) is primarily focused on discovering and developing for phosphate in British Columbia. The company recently acquired two phosphate projects in the interior of British Columbia, each offering the opportunity of a multi-deposit discovery. The Baker Basin Project, flagship project of Pacific Ridge, is located in an emerging uranium district in south-western Nunavut. Baker is over 190,000 hectares in size and is known to host at least 20 uranium prospects. For further information, visit the Company's web site at www.pacificridgeexploration.com.

Continue Reading

MondayNov 03, 2008 4:44 am

BNK Petroleum Inc. (TSX: BKX CN)

BNK Petroleum Inc. (TSX: BKX CN), a California-based energy company, is focused on acquiring, exploring, and producing large oil and gas reserves. The company operates in the United States through its wholly-owned subsidiary BNK Petroleum (US) Inc., with properties located in Oklahoma, Texas, New York, Mississippi and Alabama. BNK Petroleum aggressively targets growth in production and reserves by tactically leveraging new and proven technologies. For further information, visit the Company's web site at www.bnkpetroleum.com.

Continue Reading

MondayNov 03, 2008 4:43 am

Oxygen Biotherapeutics, Inc. (OTC BB: OXBO)

Oxygen Biotherapeutics, Inc. (OTC BB: OXBO), previously known as Synthetic Blood International, Inc., is focused on transforming patient care through the development of advanced oxygen-based therapies using Oxycyte®, the company’s perfluorocarbon (PFC) therapeutic oxygen carrier, and other solutions. Oxycyte could potentially be used in numerous indications, including traumatic brain injury, sickle-cell pain crisis, decompression sickness, stroke, heart attack, and wound treatment. For further information, visit the Company's web site at www.oxybiomed.com.

Continue Reading

MondayNov 03, 2008 4:43 am

Blue Note Mining (TSX: BN)

Blue Note Mining (TSX: BN CN) was founded with the purpose of taking advantage of Canadian metals mining opportunities. The company’s first asset acquisition was the Caribou and Restigouche lead-zinc mines located near Bathurst, New Brunswick. Blue Note intends to make other corporate and asset acquisitions in the near term future. Their exploration strategy is focused on providing a continuous source of sulphide ore feed for the concentrator at the Caribou mine/mill complex. For further information, visit the Company's web site at www.bluenotemining.ca.

Continue Reading

MondayNov 03, 2008 4:43 am

OXiGENE, Inc. (NASDAQ: OXGN)

OXiGENE, Inc. (NASDAQ: OXGN), a biopharmaceutical company, is focused on finding and developing new and improved therapeutics that attend to the substantial, but unmet needs of patients diagnosed with cancer and eye disease. The company’s primary focus is on the development and commercialization of first-in-class and best-in-class vascular disrupting agents (VDAs) designed to treat cancer and eye disease. To date, OXiGENE's VDA product candidates have shown considerable potential in human clinical studies. For further information, visit the Company's web site at www.oxigene.com.

Continue Reading

MondayNov 03, 2008 4:42 am

Osteologix, Inc. (OTC BB: OLGX)

Osteologix, Inc. (OTC BB: OLGX), a specialty biopharmaceutical company, has dedicated their efforts to improving the health of those afflicted with musculoskeletal diseases through the development of innovative therapies. NB S101, the company’s lead investigational product candidate, is an innovative pharmaceutical agent designed to treat and prevent osteoporosis. Their mission is to partner with the healthcare community to apply new scientific information to the development of beneficial products. For more information please visit www.osteologix.com.

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered